Abstrakt
JCO published international guidelines for management of hematologic malignancies during pregnancy. The most common malignancy is Hodgkin disease, which usually has an excellent prognosis.
Typically, it can be treated by ABVD during the second and third trimesters. There is insufficient data about BEACOPP during pregnancy.
For non-Hodgkin disease, steroids could be used in the first trimester, while chemotherapy could be administered during the second and third trimesters.